Literature DB >> 11517264

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

J Ko1, S Humbert, R T Bronson, S Takahashi, A B Kulkarni, E Li, L H Tsai.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) plays a pivotal role in brain development and neuronal migration. Cdk5 is abundant in postmitotic, terminally differentiated neurons. The ability of Cdk5 to phosphorylate substrates is dependent on activation by its neuronal-specific activators p35 and p39. There exist striking differences in the phenotypic severity of Cdk5-deficient mice and p35-deficient mice. Cdk5-null mutants show a more severe disruption of lamination in the cerebral cortex, hippocampus, and cerebellum. In addition, Cdk5-null mice display perinatal lethality, whereas p35-null mice are viable. These discrepancies have been attributed to the function of other Cdk5 activators, such as p39. To understand the roles of p39 and p35, we created p39-null mice and p35/p39 compound-mutant mice. Interestingly, p39-null mice show no obvious detectable abnormalities, whereas p35(-/-)p39(-/-) double-null mutants are perinatal lethal. We show here that the p35(-/-)p39(-/-) mutants exhibit phenotypes identical to those of the Cdk5-null mutant mice. Other compound-mutant mice with intermediate phenotypes allow us to determine the distinct and redundant functions between p35 and p39. Our data strongly suggest that p35 and p39 are essential for Cdk5 activity during the development of the nervous system. Thus, p35 and p39 are likely to be the principal, if not the only, activators of Cdk5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517264      PMCID: PMC6763073     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5).

Authors:  A C Pant; H C Pant; N Amin
Journal:  Brain Res       Date:  1997-08-15       Impact factor: 3.252

2.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

Authors:  M Zheng; C L Leung; R K Liem
Journal:  J Neurobiol       Date:  1998-05

3.  Molecular cloning and characterisation of a mouse gene encoding an isoform of the neuronal cyclin-dependent kinase 5 (CDK5) activator.

Authors:  F Nildén; A Bäckström; C Bark
Journal:  Biochim Biophys Acta       Date:  1998-07-09

4.  Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain.

Authors:  K Ishiguro; S Kobayashi; A Omori; M Takamatsu; S Yonekura; K Anzai; K Imahori; T Uchida
Journal:  FEBS Lett       Date:  1994-04-04       Impact factor: 4.124

5.  A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function.

Authors:  N E Faulkner; D L Dujardin; C Y Tai; K T Vaughan; C B O'Connell; Y Wang; R B Vallee
Journal:  Nat Cell Biol       Date:  2000-11       Impact factor: 28.824

6.  Synaptic localization of p39, a neuronal activator of cdk5.

Authors:  S Humbert; L M Lanier; L H Tsai
Journal:  Neuroreport       Date:  2000-07-14       Impact factor: 1.837

Review 7.  Extracellular matrix in early cortical development.

Authors:  A L Pearlman; A M Sheppard
Journal:  Prog Brain Res       Date:  1996       Impact factor: 2.453

8.  Selective disruption of "late onset" sagittal banding patterns by ectopic expression of engrailed-2 in cerebellar Purkinje cells.

Authors:  S L Baader; M W Vogel; S Sanlioglu; X Zhang; J Oberdick
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

9.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome.

Authors:  Y Feng; E C Olson; P T Stukenberg; L A Flanagan; M W Kirschner; C A Walsh
Journal:  Neuron       Date:  2000-12       Impact factor: 17.173

View more
  124 in total

Review 1.  Molecular control of neuronal migration.

Authors:  Hwan Tae Park; Jane Wu; Yi Rao
Journal:  Bioessays       Date:  2002-09       Impact factor: 4.345

2.  Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).

Authors:  Paola Giusti-Rodríguez; Jun Gao; Johannes Gräff; Damien Rei; Takahiro Soda; Li-Huei Tsai
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

Review 3.  Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex.

Authors:  Kenneth Y Kwan; Nenad Sestan; E S Anton
Journal:  Development       Date:  2012-05       Impact factor: 6.868

Review 4.  Application of in utero electroporation and live imaging in the analyses of neuronal migration during mouse brain development.

Authors:  Yoshiaki V Nishimura; Tomoyasu Shinoda; Yutaka Inaguma; Hidenori Ito; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

5.  Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling.

Authors:  Vishaldeep K Sidhu; Bill X Huang; Hee-Yong Kim
Journal:  J Proteome Res       Date:  2011-10-26       Impact factor: 4.466

6.  CDK-5 regulates the abundance of GLR-1 glutamate receptors in the ventral cord of Caenorhabditis elegans.

Authors:  Peter Juo; Tom Harbaugh; Gian Garriga; Joshua M Kaplan
Journal:  Mol Biol Cell       Date:  2007-08-01       Impact factor: 4.138

7.  RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.

Authors:  Yuan Xiao Zhu; Rodger Tiedemann; Chang-Xin Shi; Holly Yin; Jessica E Schmidt; Laura A Bruins; Jonathan J Keats; Esteban Braggio; Chris Sereduk; Spyro Mousses; A Keith Stewart
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

Review 8.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.

Authors:  Patrice D Smith; Stephen J Crocker; Vernice Jackson-Lewis; Kelly L Jordan-Sciutto; Shawn Hayley; Matthew P Mount; Michael J O'Hare; Steven Callaghan; Ruth S Slack; Serge Przedborski; Hymie Anisman; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

10.  Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration.

Authors:  David Muyllaert; Dick Terwel; Anna Kremer; Kristina Sennvik; Peter Borghgraef; Herman Devijver; Ilse Dewachter; Fred Van Leuven
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.